{"pmid":32286694,"title":"Letter: Covid-19 and vitamin D-authors' reply.","text":["Letter: Covid-19 and vitamin D-authors' reply.","We read with great interest the letter from Drs Panarese and Shahini, regarding our review article. We are glad that our review has helped Italian colleagues in this pandemic and grateful for their comments. Interestingly, they found that northerly latitude is associated with increased mortality rate and hospitalization rate for COVID-19 worldwide.","Aliment Pharmacol Ther","Tian, Yuan","Rong, Long","32286694"],"abstract":["We read with great interest the letter from Drs Panarese and Shahini, regarding our review article. We are glad that our review has helped Italian colleagues in this pandemic and grateful for their comments. Interestingly, they found that northerly latitude is associated with increased mortality rate and hospitalization rate for COVID-19 worldwide."],"journal":"Aliment Pharmacol Ther","authors":["Tian, Yuan","Rong, Long"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32286694","week":"202016|Apr 13 - Apr 19","doi":"10.1111/apt.15764","source":"PubMed","weight":0,"locations":["Panarese","Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"_version_":1664071627197906947,"score":8.233237,"similar":[{"pmid":32294264,"title":"Cutaneous manifestations in COVID-19: a new contribution.","text":["Cutaneous manifestations in COVID-19: a new contribution.","We have read with great interest Dr Recalcati's review about skin manifestations in COVID-19 as it is the first report on this subject(1) . In a recent review on clinical characteristics of coronavirus disease 2019 in China, rash was observed in 0,2% of cases(2) . However, from the trained eyes of a dermatologist, this percentage may be higher.","J Eur Acad Dermatol Venereol","Estebanez, Andrea","Perez-Santiago, Leticia","Silva, Esmeralda","Guillen-Climent, Santiago","Garcia-Vazquez, Alejandro","Ramon, M Dolores","32294264"],"abstract":["We have read with great interest Dr Recalcati's review about skin manifestations in COVID-19 as it is the first report on this subject(1) . In a recent review on clinical characteristics of coronavirus disease 2019 in China, rash was observed in 0,2% of cases(2) . However, from the trained eyes of a dermatologist, this percentage may be higher."],"journal":"J Eur Acad Dermatol Venereol","authors":["Estebanez, Andrea","Perez-Santiago, Leticia","Silva, Esmeralda","Guillen-Climent, Santiago","Garcia-Vazquez, Alejandro","Ramon, M Dolores"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294264","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jdv.16474","keywords":["COVID-19","cutaneous","cutaneous manifestations","skin"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664266295631151104,"score":115.0166},{"pmid":32291906,"title":"Reply to the comment.","text":["Reply to the comment.","We appreciate the opportunity to respond to the comments by Dr. Marongiu et al., they presented that as only laboratory findings of Disseminated Intravascular Coagulation (DIC) but no bleeding was mentioned, indicating that there was not an overt DIC in our patients, instead, the abnormal laboratory findings could be an expression of local DIC, i.e. a pulmonary vascular thrombosis. Thus they suggested the anticoagulant treatment in patients with coronavirus disease 2019 (COVID-19).","J Thromb Haemost","Tang, Ning","32291906"],"abstract":["We appreciate the opportunity to respond to the comments by Dr. Marongiu et al., they presented that as only laboratory findings of Disseminated Intravascular Coagulation (DIC) but no bleeding was mentioned, indicating that there was not an overt DIC in our patients, instead, the abnormal laboratory findings could be an expression of local DIC, i.e. a pulmonary vascular thrombosis. Thus they suggested the anticoagulant treatment in patients with coronavirus disease 2019 (COVID-19)."],"journal":"J Thromb Haemost","authors":["Tang, Ning"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32291906","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jth.14843","source":"PubMed","weight":0,"_version_":1664266295762223105,"score":106.85941},{"pmid":32281653,"title":"Reply to: \"Reporting of all cardiac medications and their outcome in COVID-19\".","text":["Reply to: \"Reporting of all cardiac medications and their outcome in COVID-19\".","We thank Dr. Ajay Kumar Mishra and his colleagues for their attention to our review.(1, 2) We strongly agree with them that it is inappropriate for COVID-19 patients to discontinue ACEIs /ARBs without weighing up the pros and cons.(3, 4) Whether the RAAS inhibitors may affect the prognosis of COVID-19 patients still needs more clinical trials to confirm. This article is protected by copyright. All rights reserved.","J Med Virol","Cheng, Hao","Wang, Yan","Wang, Gui-Qiang","32281653"],"abstract":["We thank Dr. Ajay Kumar Mishra and his colleagues for their attention to our review.(1, 2) We strongly agree with them that it is inappropriate for COVID-19 patients to discontinue ACEIs /ARBs without weighing up the pros and cons.(3, 4) Whether the RAAS inhibitors may affect the prognosis of COVID-19 patients still needs more clinical trials to confirm. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Cheng, Hao","Wang, Yan","Wang, Gui-Qiang"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32281653","week":"202016|Apr 13 - Apr 19","doi":"10.1002/jmv.25868","source":"PubMed","weight":0,"_version_":1664182200748212226,"score":106.0229},{"pmid":32302445,"title":"Reply to \"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy\".","text":["Reply to \"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy\".","We have just read with interest the article recently published in your Journal and titled \"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy\" by Tang N. et al (1). In this article, it is suggested that those patients with COVID-19 that accomplish the Sepsis-Induced Coagulopathy (SIC) criteria, and receive anticoagulant treatment would present a reduction of mortality rates. It is well known that both shock and disseminated intravascular coagulation (DIC) are the two major causes of organ dysfunction in sepsis (2). Furthermore, DIC is a strong predictor of mortality in patients with sepsis, independently of the severity of sepsis (2).","J Thromb Haemost","Coto-Hernandez, Ruben","Fabregas Ruano, Maria Teresa","32302445"],"abstract":["We have just read with interest the article recently published in your Journal and titled \"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy\" by Tang N. et al (1). In this article, it is suggested that those patients with COVID-19 that accomplish the Sepsis-Induced Coagulopathy (SIC) criteria, and receive anticoagulant treatment would present a reduction of mortality rates. It is well known that both shock and disseminated intravascular coagulation (DIC) are the two major causes of organ dysfunction in sepsis (2). Furthermore, DIC is a strong predictor of mortality in patients with sepsis, independently of the severity of sepsis (2)."],"journal":"J Thromb Haemost","authors":["Coto-Hernandez, Ruben","Fabregas Ruano, Maria Teresa"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302445","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jth.14852","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664357978651754498,"score":101.105705},{"pmid":32227489,"title":"Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysis.","text":["Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysis.","I read with interest the meta-analysis of patient clinical characteristics and fatality rates in COVID-19 from Chinese samples by Li and colleagues(1) . I was surprised by the fatality rate of 7% which is much than higher than the value of 1.4% reported in a large study of Chinese patients by Guan et al (2020)(2) . This article is protected by copyright. All rights reserved.","J Med Virol","Kempton, Matthew","32227489"],"abstract":["I read with interest the meta-analysis of patient clinical characteristics and fatality rates in COVID-19 from Chinese samples by Li and colleagues(1) . I was surprised by the fatality rate of 7% which is much than higher than the value of 1.4% reported in a large study of Chinese patients by Guan et al (2020)(2) . This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Kempton, Matthew"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32227489","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25799","source":"PubMed","locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1663352135309328384,"score":96.91032}]}